1,490
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Flavonolignan Production in Cell Suspension Culture of Silybum marianum

, , &
Pages 876-882 | Accepted 27 May 2008, Published online: 20 Jan 2009

Figures & data

Figure 1. Structure of silybin A (1), silybin B (2), isosilybin A (3) and isosilybin B (4)

Figure 1.  Structure of silybin A (1), silybin B (2), isosilybin A (3) and isosilybin B (4)

Table 1. HPLC gradient solvent program.

Figure 2. Growth of callus of Silybum marianum from leaf (□), shoot (▪) and root (▵) segments on MS media. Data are the averages of three experiments in triplicate (means ± S.E.).

Figure 2.  Growth of callus of Silybum marianum from leaf (□), shoot (▪) and root (▵) segments on MS media. Data are the averages of three experiments in triplicate (means ± S.E.).

Figure 3. Effect of different treatments on flavonolignan (%) accumulation in calli culture culture of S. marianum. Treatments refer to: Pic (1, 2 or 3 mg l−1), Kin (A) (0.4, 0.8 or 1.5 mg l−1) and: BAP (B) (0.4, 0.8 or 1.5 mg l−1) after 60 (□) and 90 (▪) days. Data are the averages of three experiments; in triplicate (means ± S.E.).

Figure 3.  Effect of different treatments on flavonolignan (%) accumulation in calli culture culture of S. marianum. Treatments refer to: Pic (1, 2 or 3 mg l−1), Kin (A) (0.4, 0.8 or 1.5 mg l−1) and: BAP (B) (0.4, 0.8 or 1.5 mg l−1) after 60 (□) and 90 (▪) days. Data are the averages of three experiments; in triplicate (means ± S.E.).

Figure 4. Chromatogram of methanolic extract from callus cultures of S. marianum on MS media supplemented with 3 mg l−1 picloram and 0.4 mg l−1 kinetin.

Figure 4.  Chromatogram of methanolic extract from callus cultures of S. marianum on MS media supplemented with 3 mg l−1 picloram and 0.4 mg l−1 kinetin.

Figure 5. Effect of different treatments on biomass accumulation (A) and flavonolignan content (%) (B) in cell suspension culture of S. marianum on day 28 under light and dark conditions. Treatments refer to: 1: Pic (3 mg l−1); 2: Pic (3 mg l−1) and JA (2 mg l−1); 3: Pic (2 mg l−1); 4; Pic (2 mg l−1) and JA (2 mg l−1). Data are the averages of three experiments in triplicate (means ± .S.E.).

Figure 5.  Effect of different treatments on biomass accumulation (A) and flavonolignan content (%) (B) in cell suspension culture of S. marianum on day 28 under light and dark conditions. Treatments refer to: 1: Pic (3 mg l−1); 2: Pic (3 mg l−1) and JA (2 mg l−1); 3: Pic (2 mg l−1); 4; Pic (2 mg l−1) and JA (2 mg l−1). Data are the averages of three experiments in triplicate (means ± .S.E.).

Figure 6. Influence of different treatments on the number of cells in suspension culture of S. marianum on days 7, 14, 21 and 28 under light and dark conditions. Treatments refer to: ▵: Pic (3 mg l−1); ▵: Pic (3 mg l−1) and JA (2 mg l−1); ▪: Pic (2 mg l−1); □: Pic (2 mg l−1) and JA (2 mg l−1). Data are the averages of three experiments in triplicate (means ± S.E.).

Figure 6.  Influence of different treatments on the number of cells in suspension culture of S. marianum on days 7, 14, 21 and 28 under light and dark conditions. Treatments refer to: ▵: Pic (3 mg l−1); ▵: Pic (3 mg l−1) and JA (2 mg l−1); ▪: Pic (2 mg l−1); □: Pic (2 mg l−1) and JA (2 mg l−1). Data are the averages of three experiments in triplicate (means ± S.E.).

Table 2. Flavonolignan content in cell suspension culture of Silybum marianum grown in media supplemented with 3 mg l− 1 Pic and 2 mg l l− 1 JA in dark conditions. Component were determined and quantified by by HPLC analysis. (Taxifolin, TXF; Silychristin, SCN; Silydianin, SDN; Silybin, SBN; Isosilybin, ISBN and Silymarin (SLM)). Data are the averages of three experiments in triplicate (means± S.E.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.